DADC
BHC icon

D.A. Davidson & Co’s Bausch Health BHC Stock Holding History

D.A. Davidson & Co’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-26,460
Closed -$410K – 943
2020
Q1 		$410K Sell
26,460
-2,200
-8% -$53K 0.01% 637
2019
Q4 		$858K Sell
28,660
-1,700
-6% -$44.2K 0.01% 543
2019
Q3 		$663K Buy
30,360
+750
+3% +$17.2K 0.01% 585
2019
Q2 		$747K Buy
29,610
+2,700
+10% +$64.1K 0.01% 535
2019
Q1 		$665K Buy
26,910
+8,700
+48% +$208K 0.01% 603
2018
Q4 		$336K Buy
18,210
+1,900
+12% +$45.2K 0.01% 780
2018
Q3 		$419K Buy
+16,310
New +$373K 0.01% 779
2017
Q3 		– Sell
-1,000
Closed -$17K – 1168
2017
Q2 		$17K Sell
1,000
-4,446
-82% -$53.3K ﹤0.01% 1859
2017
Q1 		$60K Buy
5,446
+1,591
+41% +$21.9K ﹤0.01% 1447
2016
Q4 		$55K Sell
3,855
-2,125
-36% -$39K ﹤0.01% 1555
2016
Q3 		$146K Buy
5,980
+1,103
+23% +$28.5K ﹤0.01% 1081
2016
Q2 		$97K Buy
4,877
+1,125
+30% +$31.9K ﹤0.01% 1140
2016
Q1 		$98K Buy
3,752
+2,160
+136% +$160K ﹤0.01% 1134
2015
Q4 		$161K Sell
1,592
-31,726
-95% -$3.56M 0.01% 922
2015
Q3 		$5.94M Sell
33,318
-234
-0.7% -$54.6K 0.21% 100
2015
Q2 		$7.45M Sell
33,552
-1,078
-3% -$239K 0.24% 84
2015
Q1 		$6.88M Buy
34,630
+21
+0.1% +$3.73K 0.23% 93
2014
Q4 		$4.95M Buy
34,609
+1,221
+4% +$164K 0.16% 124
2014
Q3 		$4.38M Sell
33,388
-730
-2% -$87K 0.15% 131
2014
Q2 		$4.3M Buy
34,118
+142
+0.4% +$18.1K 0.15% 136
2014
Q1 		$4.48M Sell
33,976
-514
-1% -$70.3K 0.16% 125
2013
Q4 		$4.05M Buy
34,490
+339
+1% +$37.1K 0.15% 131
2013
Q3 		$3.56M Buy
34,151
+708
+2% +$69K 0.16% 128
2013
Q2 		$2.88M Buy
+33,443
New +$2.64M 0.14% 148

Other funds holding BHC

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

D.A. Davidson & Co's BHC Position: Q2 2020 in Review

D.A. Davidson & Co sold out of Bausch Health (BHC) in Q2 2020, closing a stake of 26,460 shares — an estimated $410K sold.

D.A. Davidson & Co first reported a position in BHC in Q2 2013 and held it in 24 quarters. The position peaked at $7.45M in Q2 2015. 303 funds tracked by Wall St. Rank hold BHC as of Q2 2020.

  • D.A. Davidson & Co reported no remaining Bausch Health position as of Q2 2020 after selling out during the quarter.
  • D.A. Davidson & Co sold 26,460 Bausch Health shares in Q2 2020, an estimated $410K.
  • D.A. Davidson & Co first reported a position in Bausch Health in Q2 2013 and held it in 24 quarters.
  • D.A. Davidson & Co's Bausch Health position peaked at $7.45M in Q2 2015.
  • 303 funds tracked by Wall St. Rank held Bausch Health as of Q2 2020.

Based on D.A. Davidson & Co's 13F filing for Q2 2020, filed 10 Aug 2020.